News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 7, 2024
BEDFORD, Mass., June 7, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3, 2024, Anika...
-
May 28, 2024
Appoints Joseph Capper and William Jellison to Board of Directors Announces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a...
-
May 8, 2024
Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024 BEDFORD, MASS., May 8, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early...
-
May 8, 2024
Revenue up 7% on growing demand and favorable order timing; On-track for 2024 revenue guidance Cost reduction initiatives complete; On-track to achieve 2024 adjusted EBITDA guidance of $25-30...
-
May 3, 2024
BEDFORD, Mass., May 3, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024, Anika granted...
-
Apr 18, 2024
BEDFORD, Mass., April 18, 2024 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Apr 2, 2024
BEDFORD, Mass. — April 2, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Mar 13, 2024
BEDFORD, Mass., March 13, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its...
-
Mar 8, 2024
BEDFORD, Mass., March 8, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on March 1, 2024, Anika...
-
Feb 27, 2024
BEDFORD, Mass., February 27, 2024 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Feb 13, 2024
Announcing the limited market release of X-TwistÔ Fixation System with biocomposite suture anchor for rotator cuff and other soft tissue repair at AAOS Focusing on its full Regenerative, Sports...
-
Nov 28, 2023
Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative portfolio BEDFORD,...
-
Nov 7, 2023
BEDFORD, Mass., November 7, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard,...
-
Nov 2, 2023
Revenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management up 2% and 11%, Respectively RevoMotionâ„¢...
-
Oct 10, 2023
BEDFORD, Mass., October 10, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Sep 19, 2023RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S. reverse shoulder market
RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S....
-
Sep 15, 2023
BEDFORD, Mass., September 15, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 5, 2023,...
-
Sep 12, 2023
BEDFORD, Mass. — September 12, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Aug 17, 2023Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received the...
-
Aug 8, 2023
Double Digit Q2 Revenue Growth Driven by Strong OA Pain Management Growth of 22%; Raising Low-End of Full-Year Guidance Range on Positive Year-to-Date Performance Hyalofast®, Single-Stage,...
-
Jul 20, 2023
BEDFORD, Mass., July 20, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Jul 12, 2023
Anika’s new X-Twist™ Fixation System, combined with its ACE Award-Winning Tactoset® for hardware augmentation and autologous bone morrow aspirate, provide time-saving regenerative solutions...
-
May 30, 2023
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair is marketed in over 35 countries outside the U.S. where it has been clinically demonstrated...
-
May 9, 2023Positive Start to 2023 Revenue Growth with OA Pain Management Up 8% and Joint Preservation and Restoration Up 11%
BEDFORD, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
-
Apr 19, 2023
BEDFORD, Mass., April 19, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...